✦ LIBER ✦

LITHIUM AND M.R.I.H. IN TARDIVE DYSKINESIA

✍ Scribed by Ehrensing, RudolphH.

Book ID: 122823577
Publisher: The Lancet
Year: 1974
Tongue: English
Weight: 275 KB
Volume: 304
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(74)90127-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lithium and lecithin in tardive dyskines

Lithium and lecithin in tardive dyskinesia: An update

✍ Jan Volavka; Jane O'Donell; Raj Muragali; Brian G. Anderson; Pedro Gaztanaga; Wi 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 290 KB

LITHIUM THERAPY IN HUNTINGTON'S CHOREA A

LITHIUM THERAPY IN HUNTINGTON'S CHOREA AND TARDIVE DYSKINESIA

✍ Dalén, Per 📂 Article 📅 1973 🏛 The Lancet 🌐 English ⚖ 307 KB

Bereitschaftspotential in tardive dyskin

Bereitschaftspotential in tardive dyskinesia

✍ Dr. Lawrence E. Adler; Mark Pecevich; Herbert Nagamoto 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

The bereitschaftspotential or motor readiness potential is a slow negative electroencephalographic wave occurring 150-1500 ms prior to the onset of a voluntary movement. It was measured in 33 subjects: 11 normal controls, 11 medicated schizophrenics with no tardive dyskinesia or evidence of drug-ind

Clozapine in tardive dyskinesia

✍ George M. Simpson; J. Hillary Lee; Ram K. Shrivastava 📂 Article 📅 1978 🏛 Springer 🌐 English ⚖ 468 KB

Naloxone in tardive dyskinesia

✍ I. Blum; P. F. Nisipeanu; E. Roberts 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 90 KB

Sulpiride in tardive dyskinesia

✍ Daniel E. Casey; Jes Gerlach; Hans Simmelsgaard 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 407 KB

Tardive dyskinesia can be suppressed by drugs that block dopaminergic receptors, but often at the cost of a concomitant increase in parkinsonism. Sulpiride (400 -- 2100 mg/day), a selective type-2 dopamine receptor antagonist, was evaluated in a blind, placebo-controlled trial in 11 patients with ta